» Articles » PMID: 30400620

Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet

Overview
Journal Nutrients
Date 2018 Nov 8
PMID 30400620
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is an escalating global epidemic caused by an imbalance between energy intake and expenditure. (-)-Epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, has been reported to be conducive to preventing obesity and alleviating obesity-related chronic diseases. However, the role of EGCG in energy metabolism disorders and central nervous system dysfunction induced by a high-fat diet (HFD) remains to be elucidated. The aim of this study was to evaluate the effects of EGCG on brown adipose tissue (BAT) thermogenesis and neuroinflammation in HFD-induced obese C57BL/6J mice. Mice were randomly divided into four groups with different diets: normal chow diet (NCD), normal chow diet supplemented with 1% EGCG (NCD + EGCG), high-fat diet (HFD), and high-fat diet supplemented with 1% EGCG (HFD + EGCG). Investigations based on a four-week experiment were carried out including the BAT activity, energy consumption, mRNA expression of major inflammatory cytokines in the hypothalamus, nuclear factor-kappa B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) phosphorylation, and immunofluorescence staining of microglial marker Iba1 in hypothalamic arcuate nucleus (ARC). Experimental results demonstrated that dietary supplementation of EGCG significantly inhibited HFD-induced obesity by enhancing BAT thermogenesis, and attenuated the hypothalamic inflammation and microglia overactivation by regulating the NF-κB and STAT3 signaling pathways.

Citing Articles

EGCG Suppresses Adipogenesis and Promotes Browning of 3T3-L1 Cells by Inhibiting Notch1 Expression.

Wang Y, Li C, Peng W, Sheng J, Zi C, Wu X Molecules. 2024; 29(11).

PMID: 38893431 PMC: 11173936. DOI: 10.3390/molecules29112555.


Coffee, tea, and cocoa in obesity prevention: Mechanisms of action and future prospects.

Wang Q, Hu G, Qiu M, Cao J, Xiong W Curr Res Food Sci. 2024; 8:100741.

PMID: 38694556 PMC: 11061710. DOI: 10.1016/j.crfs.2024.100741.


Is Propolis a Potential Anti-Obesogenic Agent for Obesity?.

Tek N, Senture S, Ersoy N Curr Nutr Rep. 2024; 13(2):186-193.

PMID: 38436884 PMC: 11133030. DOI: 10.1007/s13668-024-00524-0.


Abrupt Photoperiod Changes Differentially Modulate Hepatic Antioxidant Response in Healthy and Obese Rats: Effects of Grape Seed Proanthocyanidin Extract (GSPE).

Cortes-Espinar A, Ibarz-Blanch N, Soliz-Rueda J, Calvo E, Bravo F, Mulero M Int J Mol Sci. 2023; 24(23).

PMID: 38069379 PMC: 10707189. DOI: 10.3390/ijms242317057.


A Comprehensive Review of Phytonutrients as a Dietary Therapy for Obesity.

Siddiqui S, Harahap I, Suthar P, Wu Y, Ghosh N, Castro-Munoz R Foods. 2023; 12(19).

PMID: 37835263 PMC: 10572887. DOI: 10.3390/foods12193610.


References
1.
Peng X, Nie Y, Wu J, Huang Q, Cheng Y . Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation via suppressing TLR4/NF-κB signaling pathway in high-fat diet rats. Biochem Biophys Res Commun. 2015; 462(3):245-50. DOI: 10.1016/j.bbrc.2015.04.124. View

2.
Morselli L, Claflin K, Cui H, Grobe J . Control of Energy Expenditure by AgRP Neurons of the Arcuate Nucleus: Neurocircuitry, Signaling Pathways, and Angiotensin. Curr Hypertens Rep. 2018; 20(3):25. PMC: 5882211. DOI: 10.1007/s11906-018-0824-8. View

3.
Wisse B, Schwartz M . Does hypothalamic inflammation cause obesity?. Cell Metab. 2009; 10(4):241-2. DOI: 10.1016/j.cmet.2009.09.003. View

4.
Schwartz M, Woods S, Porte Jr D, Seeley R, Baskin D . Central nervous system control of food intake. Nature. 2000; 404(6778):661-71. DOI: 10.1038/35007534. View

5.
Shi S, Zhang W, Luk C, Sivasubramaniyam T, Brunt J, Schroer S . JAK2 promotes brown adipose tissue function and is required for diet- and cold-induced thermogenesis in mice. Diabetologia. 2015; 59(1):187-196. DOI: 10.1007/s00125-015-3786-2. View